Skip to content

Geographic atrophy secondary to AMD, results in irreversible loss of vision in sufferers and has a high unmet medical need. It is estimated that roughly 1.6 million individuals in the U.S. have GA in a minimum of one eye1. “We are pleased to reach an settlement with Iveric Bio, a company with exceptional expertise in…

Read More